News Quantified

NVAX – novavax, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX

How Technology Makes The CFO's Job More About Driving Value [Forbes]

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX

How Health, Innovation And A Bit Of Friction Help Pharmavite Succeed [Forbes]

-5.9%

BEAT

25.9%

MISS

-28.2%

MISS

Form 8-K NOVAVAX INC For: Nov 19

Form 4 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra

Form 3 NOVAVAX INC For: Nov 11 Filed by: Draghia-Akli Ruxandra

Form SC 13G/A NOVAVAX INC Filed by: VANGUARD GROUP INC

Form 10-Q NOVAVAX INC For: Sep 30

Top News Gainers

8/14 Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock. 40.5%

5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%

3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%

11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%

1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%

3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%

4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%

2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%

12/31 Form S-3 NOVAVAX INC 13.7%

6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%

Top News Decliners

3/2 Form 8-K NOVAVAX INC For: Mar 02 -28.2%

1/21 Form 424B5 NOVAVAX INC -22.9%

3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%

3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%

3/11 Form S-3ASR NOVAVAX INC -17.9%

3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%

1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%

3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%

5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%

4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day